Notice of final decisions to amend (or not amend) the current Poisons Standard, November 2019

This web publication constitutes a notice for the purposes of regulation 42ZCZS and regulation 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulations 42ZCZS and 42ZCZX, this notice publishes:

• the decisions made by a delegate of the Secretary pursuant to regulations 42ZCZR and 42ZCZU;
• the reasons for those final decisions; and
• the date of effect of those decisions.

Contents

• 1. Advisory Committee on Medicines Schedule (ACMS #27) - Final decisions made pursuant to regulation 42ZCZR
  • 1.1. Final decision in relation to phenpromethamine
  • 1.2. Final decision in relation to 1,4-Dimethylpentylamine (DMPA)
  • 1.3. Final decision in relation to sanguinarine
  • 1.4. Final decision in relation to finasteride
• 2. Joint meeting of the Advisory Committee on Chemicals and Medicines Scheduling (ACCS-ACMS #22) - Final decision made pursuant to regulation 42ZCZR
  • 2.1. Final decision in relation to arbutin
• 3. Advisory Committee on Chemicals Scheduling (ACCS #25) - Final decisions made pursuant to regulation 42ZCZR
  • 3.1. Final decision in relation to lambda-cyhalothrin
  • 3.2. Final decision in relation to sarolaner
  • 3.3. Final decision in relation to broflanilide
  • 3.4. Final decision in relation to trifludimoxazin
  • 3.5. Final decision in relation to saflufenacil
• 4. Final decisions (without interim decision) made pursuant to regulation 42ZCZU
  • 4.1. Final decision in relation to bixlozone
  • 4.2. Final decision in relation to thymol
  • 4.3. Final decision in relation to metcamifen
  • 4.4. Final decision in relation to polyacrylamide